Bruker Co. (NASDAQ:BRKR) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. decreased its holdings in shares of Bruker Co. (NASDAQ:BRKR) by 2.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 876,253 shares of the medical research company’s stock after selling 23,385 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.58% of Bruker worth $51,366,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in BRKR. FMR LLC boosted its position in shares of Bruker by 21.4% during the third quarter. FMR LLC now owns 14,306,122 shares of the medical research company’s stock worth $987,981,000 after buying an additional 2,521,904 shares during the period. Vaughan Nelson Investment Management L.P. boosted its position in shares of Bruker by 140.3% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 1,141,762 shares of the medical research company’s stock worth $66,930,000 after buying an additional 666,617 shares during the period. Point72 DIFC Ltd boosted its position in shares of Bruker by 4,875.9% during the third quarter. Point72 DIFC Ltd now owns 470,171 shares of the medical research company’s stock worth $32,470,000 after buying an additional 460,722 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Bruker by 1,933.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 410,234 shares of the medical research company’s stock worth $28,331,000 after buying an additional 390,057 shares during the period. Finally, State Street Corp boosted its position in shares of Bruker by 9.6% during the third quarter. State Street Corp now owns 3,627,300 shares of the medical research company’s stock worth $250,501,000 after buying an additional 318,808 shares during the period. Institutional investors and hedge funds own 79.52% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Barclays decreased their target price on Bruker from $69.00 to $65.00 and set an “overweight” rating for the company in a report on Monday, February 10th. UBS Group assumed coverage on Bruker in a report on Tuesday, December 10th. They issued a “neutral” rating and a $66.00 target price for the company. Bank of America lifted their target price on Bruker from $78.00 to $80.00 and gave the company a “buy” rating in a report on Friday, December 13th. The Goldman Sachs Group upgraded Bruker from a “sell” rating to a “neutral” rating and set a $60.00 target price for the company in a report on Thursday, December 5th. Finally, Stifel Nicolaus decreased their target price on Bruker from $70.00 to $57.00 and set a “hold” rating for the company in a report on Friday, February 14th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, Bruker presently has a consensus rating of “Moderate Buy” and a consensus price target of $70.50.

Bruker Stock Up 0.0 %

BRKR opened at $44.97 on Friday. The business’s 50-day simple moving average is $54.21 and its 200-day simple moving average is $58.66. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. Bruker Co. has a one year low of $44.11 and a one year high of $94.86. The stock has a market capitalization of $6.82 billion, a P/E ratio of 59.17, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18.

Bruker (NASDAQ:BRKR) last posted its earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, topping analysts’ consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. Analysts anticipate that Bruker Co. will post 2.69 EPS for the current year.

Bruker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Monday, March 17th will be given a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.44%. The ex-dividend date is Monday, March 17th. Bruker’s dividend payout ratio (DPR) is presently 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.